FOB Synthesis describes new carbapenem with activity against multidrug-resistant bacteria Oct. 17, 2011
Phase I trials assess efatutazone in Japanese and Korean patients with advanced solid tumors Oct. 17, 2011
Phase I/II data disclosed on trabedersen in melanoma, pancreatic and colorectal carcinoma Oct. 14, 2011
RSS